Cannell Capital Has Lowered Veracyte (VCYT) Holding by $10.72 Million as Shares Rose; Leucadia National Stake in Bio Techne (TECH) Has Trimmed by $722,502 as Stock Price Rose

Veracyte, Inc. (NASDAQ:VCYT) Logo

Cannell Capital Llc decreased its stake in Veracyte Inc (VCYT) by 25.27% based on its latest 2019Q1 regulatory filing with the SEC. Cannell Capital Llc sold 428,761 shares as the company’s stock rose 12.71% . The hedge fund held 1.27M shares of the health care company at the end of 2019Q1, valued at $31.72 million, down from 1.70M at the end of the previous reported quarter. Cannell Capital Llc who had been investing in Veracyte Inc for a number of months, seems to be less bullish one the $1.23B market cap company. The stock decreased 2.68% or $0.7 during the last trading session, reaching $25.43. About 93,189 shares traded. Veracyte, Inc. (NASDAQ:VCYT) has risen 160.99% since August 12, 2018 and is uptrending. It has outperformed by 160.99% the S&P500.

Leucadia National Corp decreased its stake in Bio Techne Corp (TECH) by 41.95% based on its latest 2019Q1 regulatory filing with the SEC. Leucadia National Corp sold 3,649 shares as the company’s stock rose 3.97% . The hedge fund held 5,050 shares of the biological products (no diagnostic substances) company at the end of 2019Q1, valued at $1.00 million, down from 8,699 at the end of the previous reported quarter. Leucadia National Corp who had been investing in Bio Techne Corp for a number of months, seems to be less bullish one the $7.23 billion market cap company. The stock decreased 0.58% or $1.11 during the last trading session, reaching $190.98. About 4,453 shares traded. Bio-Techne Corporation (NASDAQ:TECH) has risen 33.52% since August 12, 2018 and is uptrending. It has outperformed by 33.52% the S&P500.

Investors sentiment decreased to 1.23 in 2019 Q1. Its down 0.14, from 1.37 in 2018Q4. It dived, as 10 investors sold VCYT shares while 46 reduced holdings. 31 funds opened positions while 38 raised stakes. 30.00 million shares or 8.65% more from 27.61 million shares in 2018Q4 were reported. State Street Corp has 0% invested in Veracyte, Inc. (NASDAQ:VCYT). Morgan Stanley has invested 0% in Veracyte, Inc. (NASDAQ:VCYT). Moreover, Gsa Cap Partners Llp has 0.1% invested in Veracyte, Inc. (NASDAQ:VCYT). Laurion Mngmt Lp accumulated 0.12% or 354,814 shares. Fiera Capital Corporation reported 0.02% in Veracyte, Inc. (NASDAQ:VCYT). Bogle Investment Mngmt LP De has invested 0.38% in Veracyte, Inc. (NASDAQ:VCYT). Voloridge Inv Mgmt Ltd holds 0.01% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT) for 17,109 shares. Connor Clark And Lunn Inv Management owns 51,765 shares or 0.01% of their US portfolio. Fuller & Thaler Asset Mgmt owns 154,192 shares or 0.05% of their US portfolio. Castleark Llc holds 0.22% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT) for 238,365 shares. Rhumbline Advisers has invested 0% in Veracyte, Inc. (NASDAQ:VCYT). Grandeur Peak Global Advsr Limited Liability Corp has 43,815 shares. State Of Wisconsin Invest Board holds 0% or 37,900 shares in its portfolio. Germany-based Deutsche Bank Ag has invested 0% in Veracyte, Inc. (NASDAQ:VCYT). Us National Bank De reported 0% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT).

Since February 28, 2019, it had 0 buys, and 1 insider sale for $1.53 million activity.

More notable recent Veracyte, Inc. (NASDAQ:VCYT) news were published by: Benzinga.com which released: “The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings – Benzinga” on July 30, 2019, also Streetinsider.com with their article: “Veracyte, Inc (VCYT) PT Raised to $34 at Needham & Company – StreetInsider.com” published on July 31, 2019, Benzinga.com published: “45 Stocks Moving In Tuesday’s Mid-Day Session – Benzinga” on July 23, 2019. More interesting news about Veracyte, Inc. (NASDAQ:VCYT) were released by: Finance.Yahoo.com and their article: “Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT) – Yahoo Finance” published on June 20, 2019 as well as Seekingalpha.com‘s news article titled: “Veracyte, Inc. 2019 Q2 – Results – Earnings Call Slides – Seeking Alpha” with publication date: July 31, 2019.

Cannell Capital Llc, which manages about $347.86M and $411.38M US Long portfolio, upped its stake in Health Ins Innovations Inc (NASDAQ:HIIQ) by 110,172 shares to 888,008 shares, valued at $23.82 million in 2019Q1, according to the filing. It also increased its holding in Viad Corp (NYSE:VVI) by 10,433 shares in the quarter, for a total of 80,009 shares, and has risen its stake in Independence Hldg Co New (NYSE:IHC).

More notable recent Bio-Techne Corporation (NASDAQ:TECH) news were published by: Nasdaq.com which released: “Technology Sector Update for 07/31/2019: SMIT,BDC,LSCC,NATI – Nasdaq” on July 31, 2019, also Nasdaq.com with their article: “How Big Will the Wearable Tech Industry Become? – Nasdaq” published on August 09, 2019, Investingnews.com published: “5 Top Weekly NASDAQ Tech Stocks: SharpSpring Takes the Lead – Investing News Network” on August 12, 2019. More interesting news about Bio-Techne Corporation (NASDAQ:TECH) were released by: Nasdaq.com and their article: “3 Cybersecurity ETFs With Loads of Growth Potential – Nasdaq” published on July 17, 2019 as well as Nasdaq.com‘s news article titled: “Wall St rebounds on tech strength, eyes shift to earnings – Nasdaq” with publication date: August 01, 2019.

Investors sentiment increased to 1.23 in Q1 2019. Its up 0.25, from 0.98 in 2018Q4. It is positive, as 18 investors sold TECH shares while 90 reduced holdings. 45 funds opened positions while 88 raised stakes. 34.57 million shares or 6.09% less from 36.81 million shares in 2018Q4 were reported. Renaissance Technologies Limited Liability has 490,320 shares for 0.09% of their portfolio. D E Shaw And Inc holds 0.01% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH) for 43,988 shares. Rice Hall James And Assocs Ltd Company reported 13,396 shares. Price T Rowe Assocs Md invested in 0% or 19,582 shares. Shelton invested in 0.01% or 526 shares. Hills Commercial Bank Trust has invested 0.07% in Bio-Techne Corporation (NASDAQ:TECH). Dekabank Deutsche Girozentrale invested in 13,810 shares. Amundi Pioneer Asset Mngmt Inc invested 0.01% in Bio-Techne Corporation (NASDAQ:TECH). Wellington Management Gp Llp, Massachusetts-based fund reported 1.54 million shares. Ny State Common Retirement Fund reported 0.09% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Natixis, a France-based fund reported 13,560 shares. Champlain Inv Ptnrs Ltd has 1.25% invested in Bio-Techne Corporation (NASDAQ:TECH) for 720,090 shares. Cornerstone Advsrs holds 0% or 30 shares in its portfolio. Stephens Inv Management Grp has 0.38% invested in Bio-Techne Corporation (NASDAQ:TECH). Martingale Asset Mgmt Ltd Partnership holds 1,608 shares.

Veracyte, Inc. (NASDAQ:VCYT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.